XML 43 R32.htm IDEA: XBRL DOCUMENT v3.25.0.1
Schedule II. Condensed Financial Information of Registrant
12 Months Ended
Dec. 31, 2024
Condensed Financial Information Disclosure [Abstract]  
Schedule II. Condensed Financial Information of Registrant

Schedule II. Condensed Financial Information of Registrant

AMERISAFE, INC.

CONDENSED BALANCE SHEETS

 

 

December 31,

 

 

 

2024

 

 

2023

 

 

 

(in thousands)

 

Assets:

 

 

 

 

 

 

Investments:

 

 

 

 

 

 

Fixed maturity securities—available-for-sale, at fair value
   (amortized cost $
4,988 and $24,309 in 2024 and 2023, respectively)

 

$

4,925

 

 

$

24,283

 

Equity securities, at fair value (cost $5,110 and $7,108 in 2024
   and 2023, respectively)

 

 

8,000

 

 

 

9,857

 

Investment in subsidiaries

 

 

230,936

 

 

 

249,159

 

Total investments

 

 

243,861

 

 

 

283,299

 

Cash and cash equivalents

 

 

11,793

 

 

 

6,635

 

Deferred income taxes

 

 

685

 

 

 

880

 

Notes receivable from subsidiaries

 

 

2,007

 

 

 

1,925

 

Property and equipment, net

 

 

762

 

 

 

1,933

 

Federal income tax recoverable

 

 

1,676

 

 

 

784

 

Other assets

 

 

1,051

 

 

 

1,099

 

Total assets

 

$

261,835

 

 

$

296,555

 

Liabilities and shareholders’ equity

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

Accounts payable and other liabilities

 

 

4,494

 

 

 

4,104

 

Total liabilities

 

 

4,494

 

 

 

4,104

 

Shareholders' equity (net of Treasury stock of $42,052 and $36,929
   at December 31, 2024 and 2023, respectively)

 

 

257,341

 

 

 

292,451

 

Total liabilities and shareholders' equity

 

$

261,835

 

 

$

296,555

 

Schedule II. Condensed Financial Information of Registrant – (Continued)

AMERISAFE, INC.

CONDENSED STATEMENTS OF INCOME

 

 

Year Ended December 31,

 

 

 

2024

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Revenues

 

 

 

 

 

 

 

 

 

Net investment income

 

$

2,279

 

 

$

4,861

 

 

$

2,395

 

Net unrealized gains (losses) on equity securities

 

 

141

 

 

 

(845

)

 

 

(490

)

Fee and other income

 

 

10,395

 

 

 

8,933

 

 

 

9,533

 

Total revenues

 

 

12,815

 

 

 

12,949

 

 

 

11,438

 

Expenses

 

 

 

 

 

 

 

 

 

Other operating costs

 

 

10,395

 

 

 

8,932

 

 

 

9,533

 

Total expenses

 

 

10,395

 

 

 

8,932

 

 

 

9,533

 

Income before income taxes and equity in earnings of subsidiaries

 

 

2,420

 

 

 

4,017

 

 

 

1,905

 

Income tax expense

 

 

1,412

 

 

 

1,055

 

 

 

714

 

Gain before equity in earnings of subsidiaries

 

 

1,008

 

 

 

2,962

 

 

 

1,191

 

Equity in net income of subsidiaries

 

 

54,428

 

 

 

59,146

 

 

 

54,411

 

Net income

 

$

55,436

 

 

$

62,108

 

 

$

55,602

 

Schedule II. Condensed Financial Information of Registrant – (Continued)

AMERISAFE, INC.

CONDENSED STATEMENTS OF CASH FLOWS

 

 

Year Ended December 31,

 

 

 

2024

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Operating activities

 

 

 

 

 

 

 

 

 

Net cash provided by operating activities

 

$

2,623

 

 

$

5,591

 

 

$

6,121

 

Investing activities

 

 

 

 

 

 

 

 

 

Purchases of investments

 

 

 

 

 

(24,885

)

 

 

(31,909

)

Proceeds from sales of investments

 

 

22,502

 

 

 

35,013

 

 

 

75,950

 

Purchases of property and equipment

 

 

231

 

 

 

(482

)

 

 

(1,903

)

Dividends from subsidiary

 

 

71,000

 

 

 

56,000

 

 

 

77,700

 

Net cash provided by investing activities

 

 

93,733

 

 

 

65,646

 

 

 

119,838

 

Financing activities

 

 

 

 

 

 

 

 

 

Finance lease purchases

 

 

(85

)

 

 

(91

)

 

 

(58

)

Share-based compensation related tax withholding

 

 

(554

)

 

 

(944

)

 

 

 

Purchase of treasury stock

 

 

(5,123

)

 

 

(2,171

)

 

 

(12,388

)

Dividends to shareholders

 

 

(85,436

)

 

 

(93,307

)

 

 

(100,427

)

Net cash used in financing activities

 

 

(91,198

)

 

 

(96,513

)

 

 

(112,873

)

Change in cash and cash equivalents

 

 

5,158

 

 

 

(25,276

)

 

 

13,086

 

Cash and cash equivalents at beginning of year

 

 

6,635

 

 

 

31,911

 

 

 

18,825

 

Cash and cash equivalents at end of year

 

$

11,793

 

 

$

6,635

 

 

$

31,911